BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 10, 2007
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 9/7 cls
Biogen Idec (BIIB) Baird Christopher Raymond Price target Neutral 3% $65.78
Raymond raised his target to $68 from $60 after BIIB said it expects revenue to grow at a compound annual rate of 15% and non-GAAP EPS to grow at a 20% compound annual rate from 2007 to 2010. BIIB...

Read the full 381 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >